Metronidazole controlled release - Dr Reddy's Laboratories

Drug Profile

Metronidazole controlled release - Dr Reddy's Laboratories

Alternative Names: Metronidazole-DRF1; Metronidazole-DRF2

Latest Information Update: 17 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dr Reddys Laboratories
  • Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Small molecules
  • Mechanism of Action DNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Clostridium infections

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 17 Dec 2015 No recent reports on development identified - Phase-II for Clostridium infections in India (PO)
  • 31 Mar 2013 Dr Reddy's Laboratories completes a phase II trial in Clostridium infections in India (NCT01559545)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top